Clinical Trials for Advenchen Laboratories

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Advenchen Laboratories

Clinical Trials (6)

NCT06247605
A Phase IIII Study of AL8326 in Small Cell Lung Cancer
PHASE3Recruiting
243 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2029
1 condition1 sponsor1 location
NCT06794957
A Study of AL8326 in Non-Small Cell Lung Cancer
PHASE1Active, not recruiting
158 participants
Started: May 19, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor10 locations
NCT07179081
A Study of AL58805 in Patients With Advanced Tumors
PHASE1Recruiting
40 participants
Started: Dec 20, 2020 · Completed: Jan 26, 2026
1 condition1 sponsor1 location
NCT04165330
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
PHASE1/PHASE2Active, not recruiting
56 participants
Started: Oct 17, 2019 · Completed: Mar 31, 2028
4 conditions2 sponsors1 location
NCT03016819
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
PHASE3Active, not recruiting
325 participants
Started: Aug 15, 2017 · Completed: Jun 30, 2025
4 conditions1 sponsor23 locations
NCT02584478
Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)
PHASE3Active, not recruiting
294 participants
Started: Dec 31, 2015 · Completed: Dec 31, 2024
5 conditions1 sponsor41 locations